SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences’ arm completes acquisition of 85.6% equity shares of Amplitude Surgical SA

30 Jul 2025 Evaluate

Zydus Lifesciences’ step down subsidiary -- Zydus MedTech (France) SAS has completed block acquisition of 85.6% equity shares of Amplitude Surgical SA, France (Target Entity). As a result, Zydus MedTech France now holds 85.6% of the share capital and voting rights of the Target Entity. 

Zydus MedTech France will file on July 30, 2025, a simplified mandatory tender offer for all the remaining outstanding shares of the Target Entity at a price of Euro 6.25 per share, identical to the price paid for the Block Acquisition. Considering the undertaking received from seven shareholders to participate in tender offer representing in aggregate 4.7% of share capital and voting rights, Zydus MedTech France will be in a position to hold more than 90% of the capital and voting rights of the Target Entity upon completion of the Offer. Zydus MedTech France will subsequently request the implementation of a squeeze-out.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

923.10 7.65 (0.84%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×